Shopping Cart
- Remove All
- Your shopping cart is currently empty
Influenza A virus-IN-15 (Compound 9b), a quinoline derivative, is a broad-spectrum anti-influenza inhibitor with an IC50 range of 0.88-6.33 μM and demonstrates acceptable cytotoxicity. It inhibits the transcription and replication of viral RNA, making it suitable for research on Influenza A virus (IAV).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Influenza A virus-IN-15 (Compound 9b), a quinoline derivative, is a broad-spectrum anti-influenza inhibitor with an IC50 range of 0.88-6.33 μM and demonstrates acceptable cytotoxicity. It inhibits the transcription and replication of viral RNA, making it suitable for research on Influenza A virus (IAV). |
In vitro | Influenza A virus-IN-15 (Compound 9b) inhibits the activity of IAV, with an IC50 of 0.88 μM [1]. Influenza A virus-IN-15 effectively reduces infection of the strains A/Puerto Rico/8/34 (H1N1), A/Aichi/2/1968 (X31)(H3N2), B/Brisbane/60/2008 (B/Victoria), and B/Phuket/3073/2013 (B/Yamagata) in a dose-independent manner, with IC50 values of 3.57 μM, 4.66 μM, 5.16 μM, and 6.33 μM, respectively [1]. |
Molecular Weight | 510.587 |
Formula | C29H30N6O3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.